President Donald Trump speaks speaks on the latest developments of the coronavirus outbreak, while flanked by White House coronavirus response coordinator Debbie Birx (L), and U.S. Surgeon General Jerome Adams (R), in the James Brady Press Briefing Room at the White House March 19, 2020. (Photo by Chip Somodevilla/Getty Images)
President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
"We're going to be able to make that drug available almost immediately," Trump said.
The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.
He also tempered the president's optimism about the still-untested solution.
"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."
New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.
"The therapies are something we could move on much faster potentially," Trump said.
He claimed the administration "slashed red tape" to develop new vaccines and therapies.
The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks.
"If we find that we need something, then we will do that," he said.
Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak.
The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.
"We continue our relentless effort to defeat the Chinese virus," Trump said.
On this episode of Cheddar Reveals Richenda Sandlin-Tymitz, Marketing & Content Manager at Alaska Tour & Travel, breaks down when and how to plan your best trip to Alaska; Kristen Miller, Acting Executive Director, Alaska Wilderness League, discusses the Arctic National Wildlife Refuge and the oil drilling that threatens it; Cheddar gets a look at Curiosity Stream's 'The Magic of the Wild.'
Kristen Miller, acting executive director, Alaska Wilderness League, discusses the Arctic National Wildlife Refuge and the oil drilling that threatens it.
The Department of Treasury is warning Americans to expect delays on their tax returns this year as the IRS manages staffing shortages due to the pandemic.
The United States and Russia remain distant following a meeting between high-level officials for the two countries in Geneva, Switzerland. The nations remain conflicted over Washington's concern of a potential invasion of Ukraine by Russia and Moscow dispute with NATO expanding into former Soviet states. Hagar Chemali, host of Oh My World on YouTube and former spokesperson for the U.S. Mission to the U.N., joined Cheddar's "News Wrap" to give her take about the careful diplomatic negotiations underway. "I would expect more rounds," she said about the talks. "Both sides really remain adamant that we're not going to talk about Russia's proposal, and Russia doesn't want to talk about anything but its proposal. So once they start talking about the other items on the table, and there are a few other items, that's when negotiations can start."
Markets closed the day mixed, and well off their lows of the day following a market meltdown earlier in the session. The Nasdaq staged a comeback late in the day, even amid ongoing worries about the Federal Reserve raising interest rates. Doug Flynn, certified financial planner and co-founder of Flynn Zito Capito, joined Cheddar News' Closing Bell to discuss the markets' close and what's driving the major indexes.
Eli Yokley, Senior Reporter at Morning Consult, joins Cheddar News to discuss how Americans are prioritizing economic issues over the pandemic when it comes to voting.
President Biden's disapproval rating hit a new high in December according to a poll from CNBC and Change Research, as Americans expressed their disapproval over the current state of the economy. This comes just months after the president signed a historic infrastructure bill back in November that was promised to bring a surge of jobs, especially in the manufacturing sector.
Change Research Senior Pollster Nancy Zdunkewicz spoke to Cheddar News about just what is driving the President’s disapproval rating.
